Advertisement

Topics

The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains CFDA Approval as Medical Device for in vitro Diagnostic Use

16:23 EDT 29 Jun 2017 | Biotech-Finances

Thursday, June 29th 2017 at 11:00am UTC SHANGHAI–(BUSINESS WIRE)– SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that the AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market …

Cet article The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System
Obtains CFDA Approval as Medical Device for in vitro Diagnostic
Use
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains CFDA Approval as Medical Device for in vitro Diagnostic Use

NEXT ARTICLE

More From BioPortfolio on "The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains CFDA Approval as Medical Device for in vitro Diagnostic Use"

Advertisement
Quick Search
Advertisement
Advertisement